Upadacitinib Was Administered as a Sequential Salvage Therapy for Acute Severe Ulcerative Colitis: A Case Report
This successful intervention not only avoided colectomy but demonstrated sustained clinical and sonographic remission 16 weeks of post-treatment. Upadacitinib, with its rapid action and efficacy, shows promise in ASUC and should be supported by registration trials and real-world studies. Despite successful outcomes in this case, further validation and long-term data are necessary.
Authors
- Robert Gilmore (ORCID: https://orcid.org/0000-0002-6648-658X)
- Nicole Walker (ORCID: https://orcid.org/0000-0003-3153-9378)
- Reuben Malloy (ORCID: https://orcid.org/0000-0002-9558-5157)
- Jakob Begun (ORCID: https://orcid.org/0000-0001-5256-7672)
- Myat Myat Khaing (ORCID: https://orcid.org/0000-0002-4809-0928)
- Richard Fernandes (ORCID: https://orcid.org/0000-0002-9123-0228)
- David Huynh (ORCID: https://orcid.org/0009-0000-7750-6032)
- Emi Khoo (ORCID: https://orcid.org/0000-0003-3536-4974)
- Lin Lei (ORCID: https://orcid.org/0000-0001-6687-6898)
Institutions
- The University of Queensland (AU)
- Prince Charles Hospital (AU)
- Mater Adult Hospital (AU)
Publication Details
- Journal
- Case Reports in Gastroenterology
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1159/000542711
- Citations
- 3
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.65